首页> 美国卫生研究院文献>Immunology >Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
【2h】

Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.

机译:对人类C3受体的异花叶病:它的制备及其对扁桃体细胞的C3b和C3d受体以及红细胞和嗜中性粒细胞的C3b受体的作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Antisera directed against complement (C3) receptors on human tonsil cells were prepared and tested for their capacity to block specifically C3 receptors on various types of human cells. The antisera were capable of blocking both membrane-bound and solubilized C3 receptors of human tonsil cells. The C3b receptors of human erythrocytes and granulocytes were also blocked by the anti-C3 receptor sera. Sheep erythrocyte rosette formation was not affected. IgG-EoxA rosette formation was only slightly reduced by the anti-C3 receptor sera. Immunofluorescent staining with anti-C3 receptor sera revealed only a faint or negative staining of T cells and a distinct staining of EAC-reactive tonsil cells, lymphocytic leukaemia cells, and granulocytes. Absorption of the antisera with human serum proteins, brain, thymus, liver, EU-1 cell line cells, or trypsinized tonsil cells did not influence the capacity of the anti-C3 receptor sera to inhibit C3 receptors, whereas absorption with splenic tissue or tonsil cells completely removed the blocking activity of the anti-C3 receptor sera. Absorption with human erythrocytes or kidney removed only the inhibitory effect of the antisera on C3b receptors of tonsil cells, human erythrocytes, and granulocytes, but not on C3d receptors of tonsil cells. The results indicate that (a) the antisera prepared with the described procedure contained significant amounts of antibody against C3 receptors, (b) the receptors for C3b and C3d differe in antigenicity, and (c) the C3b receptors of tonsil cells, human erythrocytes, granulocytes, and probably glomerular cells have common antigenic sites.
机译:制备了针对人类扁桃体细胞上的补体(C3)受体的抗血清,并测试了其阻断各种类型人类细胞上的特异性C3受体的能力。该抗血清能够阻断人扁桃体细胞的膜结合的和溶解的C3受体。人红细胞和粒细胞的C3b受体也被抗C3受体血清阻断。绵羊红细胞花环的形成不受影响。 IgG-EoxA玫瑰花结的形成仅因抗C3受体血清而略有减少。抗C3受体血清的免疫荧光染色仅显示T细胞微弱或阴性染色,而EAC反应性扁桃体细胞,淋巴细胞性白血病细胞和粒细胞则明显染色。人血清蛋白,脑,胸腺,肝脏,EU-1细胞系细胞或胰蛋白酶化的扁桃体细胞吸收抗血清不会影响抗C3受体血清抑制C3受体的能力,而会被脾脏组织或扁桃体吸收细胞完全消除了抗C3受体血清的阻断活性。用人红细胞或肾脏吸收仅消除了抗血清对扁桃体细胞,人红细胞和粒细胞的C3b受体的抑制作用,而没有去除对扁桃体细胞的C3d受体的抑制作用。结果表明:(a)按照上述步骤制备的抗血清中含有大量针对C3受体的抗体,(b)C3b和C3d受体的抗原性不同,并且(c)扁桃体细胞,人红细胞的C3b受体,粒细胞,可能还有肾小球细胞都有共同的抗原位点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号